12 December 2016
Sonendo, Inc., the developer of a breakthrough technology for dentistry, announced today it has completed an equity financing totaling $35 million through new and existing investors. The financing round led by DiNovA Capital will allow Sonendo to advance the commercialization of its GentleWave® System as an alternative to standard root canal treatment and develop additional products in adjacent verticals to leverage its Multisonic Ultracleaning™ technology platform.
6 December 2016Axonics Announces First Fecal Incontinence Patients Implanted with its Miniaturized Rechargeable Sacral Neuromodulation System
Axonics Modulation Technologies, Inc., the developer of the first rechargeable Sacral Neuromodulation (r-SNM™) System for the treatment of urinary and fecal dysfunction, announced today that the first Fecal Incontinence patients were successfully implanted at the University Hospital Southampton NHS Foundation Trust in Southampton, United Kingdom.
6 December 2016
Acquisition Adds Phase IIb Product, Clinical Candidates and Novel Discovery Platform To Sienna’s Growing Pipeline.
5 December 2016Wilson Therapeutics Announces that WTX101 Meets the Primary Endpoint in Phase 2 Study in Wilson Disease
Wilson Therapeutics AB (publ), announced today that the Phase 2 study of WTX101 (bis-choline tetrathiomolybdate; Decuprate®), an investigational first in class copper modulating agent with a unique mode of action for the treatment of patients with Wilson Disease, met its primary endpoint. In the ITT population, 79% of patients achieved or maintained normalized levels of free copper, or experienced a reduction of at least 25% in free copper in blood from baseline, after 24 weeks of treatment with WTX101.
5 December 2016
4Tech Inc., a privately held clinical-stage company that is developing the breakthrough TriCinch™ System for repair of the Tricuspid heart valve, today announced the appointment of Michael Ennen, M.D., as President and Chief Executive Officer, effective immediately. Dr. Ennen succeeds co-founder Carine Schorochoff, who will continue to serve 4Tech as an advisor and board observer.